Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 6

    1.

    CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes.

    Fousteri G, Dave A, Juntti T, von Herrath M.

    J Autoimmun. 2009 Feb;32(1):70-7. Epub 2009 Jan 21.PMID: 19162441 [PubMed - indexed for MEDLINE]Related articles

    2.

    First-trimester human fetal pancreas transplantation for type 1 diabetes treatment: an alternative approach for achieving long-term graft survival?

    Fousteri G, von Herrath M.

    Diabetes. 2008 Mar;57(3):525-6. No abstract available. PMID: 18305145 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Stopping diabetes in its tracks: autologous non-myeloablative stem cell transplantation.

    Fousteri G, Hayek A, von Herrath M.

    Regen Med. 2007 Sep;2(5):845-51.PMID: 17907936 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rational development of antigen-specific therapies for type 1 diabetes.

    Fousteri G, Bresson D, von Herrath M.

    Adv Exp Med Biol. 2007;601:313-9. Review.PMID: 17713020 [PubMed - indexed for MEDLINE]Related articles

    5.

    An essential role for TNF in modulating thresholds for survival, activation, and tolerance of CD8+ T cells.

    Chatzidakis I, Fousteri G, Tsoukatou D, Kollias G, Mamalaki C.

    J Immunol. 2007 Jun 1;178(11):6735-45.PMID: 17513720 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Mucosal exposure to antigen: cause or cure of type 1 diabetes?

    Fousteri G, von Herrath M, Bresson D.

    Curr Diab Rep. 2007 Apr;7(2):91-8. Review.PMID: 17425912 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...